4DMT Presents Injection-Free Subgroup Analyses from 4D-150 P

Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher than in

Related Keywords

Park City , Utah , United States , Florida , Deerfield Beach , Japan , American , Carl Danzig , Katherine Smith , Julian Pei , Robert Kim , Nasdaq , Rand Eye Institute , European Union , Drug Administration , Exchange Commission , Linkedin , American Society Of Retina Specialists , American Society , Retina Specialists , Annual Scientific Meeting , Molecular Therapeutics , Dose Expansion , Clinical Trials , Chief Medical Officer , Population Extension , Injection Free Subgroup , Scientific Meeting , Therapeutic Vector Evolution , Nobel Prize Winning , Looking Statements , Private Securities Litigation Reform Act , Molecular Therapeutic , Quarterly Report , Investor Relations ,